Skip to main content

CordenPharma extends deal with Moderna to supply lipids for COVID-19 vaccine

Pharmaceutical company CordenPharma has extended its agreement with Moderna Inc to supply large volumes of lipids used to produce Moderna's COVID-19 vaccine candidate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.